NOLADIN ETHER

NOLADIN ETHER Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Noladin ether
CAS:222723-55-9
Package:1mg;93USD|5mg;378USD|10mg;693USD
Company Name: Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel: +86-057181025280; +8617767106207
Email: sales@molcore.com
Products Intro: Product Name:Noladin ether
CAS:222723-55-9
Purity:NLT 98% Remarks:MC542123
Company Name: Aladdin Scientific
Tel:
Email: tp@aladdinsci.com
Products Intro: Product Name:Noladin ether
CAS:222723-55-9
Purity:>=98% Package:$180.9/5mg;Bulk package Remarks:98%
Company Name:   
Tel: 821-50328103-801 18930552037
Email: 3bsc@sina.com
Products Intro: Product Name:Noladin ether;2-[(5Z,8Z,11Z,14Z)-Eicosatetraenyloxy]-1,3-propanediol
CAS:222723-55-9
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
Company Name: EMMX Biotechnology LLC  
Tel: 888-539-0666
Email: info@emmx.com
Products Intro: Product Name:Noladin ether
CAS:222723-55-9
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g

NOLADIN ETHER manufacturers

  • Noladin ether
  • Noladin ether pictures
  • $93.00 / 1mg
  • 2024-11-19
  • CAS:222723-55-9
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
NOLADIN ETHER Basic information
Product Name:NOLADIN ETHER
Synonyms:2-[(5Z,8Z,11Z,14Z)-EICOSATETRAENYLOXY]-1,3-PROPANEDIOL;2-AG ETHER;2-ARACHIDONYL GLYCERYL ETHER;2-ARACHIDONYL GLYCEROL ETHER;5Z,8Z,11Z,14Z-EICOSATETRAEN-2-GLYCERYL ETHER;NOLADIN ETHER;Noladineether;2-[(5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraen-1-yloxy]-1,3-propanediol
CAS:222723-55-9
MF:C23H40O3
MW:364.56
EINECS:200-578-6
Product Categories:Cannabinoid receptor
Mol File:222723-55-9.mol
NOLADIN ETHER Structure
NOLADIN ETHER Chemical Properties
Boiling point 488.9±45.0 °C(Predicted)
density 0.948±0.06 g/cm3(Predicted)
Fp 14℃
storage temp. Desiccate at -20°C
solubility DMF: 20 mg/ml; DMSO: 15 mg/ml; Ethanol: 25 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 500 μg/ml
pka13.92±0.10(Predicted)
form ethanol solution (10 mg/mL (1% w/v))
color colorless to light yellow
Safety Information
Hazard Codes F
Risk Statements 11
Safety Statements 7-16
RIDADR UN1170 - class 3 - PG 2 - Ethanol, solution
WGK Germany 2
MSDS Information
NOLADIN ETHER Usage And Synthesis
Description2-Arachidonyl glycerol ether (2-AG ether) selectively binds to cannabinoid (CB) receptor 1 (Kis = 21.2 and >3,000 nM for CB1 and CB2, respectively, in a radioligand binding assay). It is a potent and selective agonist of CB1 and GPR55 with EC50 values of 10, 37, and >30,000 nM for CB1, GPR55, and CB2, respectively. 2-AG ether displays the typical tetrad of CB activities in mice. It is more chemically stable than 2-AG , with an endogenous half-life of hours rather than minutes. However, it is at least 10-fold less potent than 2-AG in eliciting typical CB1-mediated responses. 2-AG ether elicits modest reductions in intraocular pressure in rabbits when administered at doses exceeding 50 μg per eye. It increases aqueous humor outflow via the CB1 receptor in the trabecular meshwork. Administration of 2-AG ether to the nucleus accumbens (0.0625-1 μg) increases dietary intake and enhances fat consumption in rats given access to both high-carbohydrate and high-fat diets.
UsesHU 310 is an endogenous GPR55 and CB1 receptors agonist. HU 310 has been shown to induce hyperglycia in rats. HU 310 can be used to investigate the biological roles of GPR55 and CB1 receptors.
DefinitionChEBI: A monoalkylglycerol that is the 2-O-arachidonyl derivative of glycerol.
Biological ActivityEndogenous agonist for the GPR55 and CB 1 receptors (EC 50 values are 10 and 37 nM respectively) that displays selectivity over CB 2 receptors (K i values are 21.2 nM and > 3mM at CB 1 and CB 2 respectively). Causes sedation, hypothermia, intestinal immobility and mild antinociception in vivo . Attenuates sensory neurotransmission in rat mesenteric arteries via GPR55. Also available as part of the Endocannabinoid Tocriset™ .
NOLADIN ETHER Preparation Products And Raw materials
Tag:NOLADIN ETHER(222723-55-9) Related Product Information
1-OCTADECANOYL-2-[(CIS,CIS,CIS,CIS)-5,8,11,14-EICOSATETRAENOYL]-SN-GLYCERO-3-PHOSPHOCHOLINE 1,2-DI5,8,11,14(ALL-CIS)EICOSATETRAENOYL-SN-GLYCERO-3-PHOSPHOCHOLINE 2-AG-D5 1-STEAROYL-2-ARACHIDONOYL-SN-GLYCEROL 2-AG 1-O-HEXADECYL-2-ARACHIDONYL-SN-GLYCERO-3-PHOSPHOCHOLINE 2-AG-D8 NOLADIN ETHER 1-STEAROYL-2-ARACHIDONOYL-PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE, (NA+ SALT) TRIARACHIDONIN PHOSPHATIDYLCHOLINE, L-ALPHA-1-STEAROYL-2-ARACHIDONYL, [ARACHIDONYL-5,6,8,9,11,12,14,15-3H(N)] 2-ARACHIDONYL GLYCEROL [ARACHIDONYL 5,6,8,9,11,12,14,15-3H(N)] 3-STERAOYL-2-ARACHIDONYL-SN-GLYCEROL PHOSPHATIDYLCHOLINE, L-ALPHA-1-PALMITOYL-, 2-ARACHIDONYL, [ARACHIDONYL-1-14C] PHOSPHATIDYLCHOLINE, L-ALPHA-1-O HEXADECYL-1-2-ARACHIDONYL, [ARACHIDONYL-5,6,8,9,11,12,14,15-3H(N)] PHOSPHATIDYLETHANOLAMINE, L-ALPHA-1-PALMITOYL, 2-ARACHIDONYL, [ARACHIDONYL-1-14C] 1-STEAROYL-2-[1-14C]ARACHIDONYL-SN-GLYCEROL L-3-PHOSPHATIDYLCHOLINE,1-STEAROYL-2-[1-14C]ARACHIDONYL

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept